2.950EUR+6.12%Mkt Cap: 70.05M $P/E: —1d ago
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubato…
Indicators:|
Key Statistics
Company
Market Cap70.05M $
Enterprise Value73.02M $
Revenue (TTM)52.51M $
Gross Profit31.13M $
Net Income (TTM)-12.76M $
Revenue/Share2.403 USD
Last Price2.950 EUR
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees280
CountryDE
SectorBasic Materials
IndustrySpecialty Chemicals
ISINDE0005203947
Valuation
P/E (Trailing)—
P/E (Forward)-7.48
PEG—
EV/EBITDA-15.70
EV/Revenue1.39
P/S1.33
P/B-16.67
EPS (TTM)-0.51
EPS (Forward)-0.39
52W Range
1.82559% of range3.740
52W High3.740 EUR
52W Low1.825 EUR
Profitability
Gross Margin57.26%
Oper. Margin-18.08%
EBITDA Margin-8.86%
Profit Margin-23.48%
ROE-637.81%
ROA-17.70%
Growth
Revenue Growth-5.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.04M $
CapEx (TTM)1.75M $
FCF Margin-22.75%
FCF Yield-17.05%
Net Debt2.96M $
Net Debt/EBITDA-0.64
Balance Sheet
Debt/Equity4.64
Current Ratio1.44
Quick Ratio0.74
Book Value/Sh-0.1770 EUR
Cash/Share0.1950 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.500 EUR
Upside (mean)+86.4%
Target Range5.000 EUR – 6.500 EUR
€5.000+86.4% to mean€6.500
# Analysts3
Ownership
Shares Out.21.85M
Float9.09M
Insiders58.36%
Institutions8.22%
Technical
SMA 502.909 (+1.4%)
SMA 2002.584 (+14.2%)
Beta0.63
S&P 52W Chg20.05%
Avg Vol (30d)5.19K
Avg Vol (10d)1.90K
Technical Indicators
RSI (14)54.9
MACD-0.0145
MACD Signal-0.0150
MACD Hist.+0.0006
BB Upper3.021 EUR
BB Middle2.861 EUR
BB Lower2.702 EUR
BB Width11.18%
ATR (14)0.1209 EUR
Vol Ratio (20d)1.18x